Comparative outcomes of influenza, severe acute respiratory syndrome coronavirus 2, and respiratory syncytial virus community-acquired pneumonia: insights from an Italian retrospective cohort study
8 affiliations
- 1Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy
- 2Department of Medical Biotechnologies, University of Siena, Siena, Italy
- 3Respiratory Unit, IRCCS Humanitas Research Hospital, Milan, Italy
- 4Emergency Department, IRCCS Humanitas Research Hospital, Milan, Italy
- 5Microbiology, IRCCS Humanitas Research Hospital, Milan, Italy
- 6Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
- 7Respiratory and Cystic Fibrosis Unit, Internal Medicine Department, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
- 8Infectious Disease Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy
Abstract
Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality worldwide. Viral pathogens, particularly influenza, respiratory syncytial virus, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are increasingly recognized as key contributors to CAP in hospitalized adults. This single-center, retrospective cohort study examined and compared the clinical characteristics and outcomes of adults hospitalized with viral CAP due to influenza, SARS-CoV-2, or respiratory syncytial virus between January 2022 and December 2023 in Milan, Italy. A total of 165 patients with laboratory-confirmed single-virus infection and clinically and radiologically confirmed pneumonia were included. Patients with SARS-CoV-2 pneumonia presented with the highest in-hospital mortality (20.9%) and 12-month all-cause mortality (51.9%). Patients with influenza, although younger, showed increased rates of cardiovascular events and intensive care unit admissions. Bacterial coinfections were most common in influenza cases. Immunocompromised status was the second most frequent comorbidity (37.6%) after arterial hypertension. These findings underscore significant differences in clinical trajectory and long-term outcomes among major viral CAP etiologies and support the need for pathogen-specific management strategies.
Related
- Genomic diversity of respiratory pathogens in clinical versus community surveillance: a comparative analysis of SARS-CoV-2, RSV, and influenza viruses in Washington State
- Influenza-associated acute respiratory deterioration fulfilling acute exacerbation criteria in hospitalized patients with interstitial lung disease: a single-center retrospective cohort study
- Respiratory Syncytial Virus infections in immunosuppressed adults <65 years old: a comparative analysis with Influenza and SARS-CoV2
- Middle East Respiratory Syndrome Coronavirus in Camels, Kazakhstan, 2025
- Serologic Testing for Middle East Respiratory Syndrome Coronavirus and SARS-CoV-2 Cross-Reactive Immune Responses, the Netherlands
BibTeX
@article{silani2026comparative,
title = {{Comparative outcomes of influenza, severe acute respiratory syndrome coronavirus 2, and respiratory syncytial virus community-acquired pneumonia: insights from an Italian retrospective cohort study}},
author = {Margherita S. Silani and Anna Stainer and Massimiliano Russo and Antonio Desai and Sofia Giuriolo and Aniello Fabio Vitale and Vincenzo Alberto Artuso and Angela Tramontano and Francesco Amati and Beatrice Clemente and Alessandra Belati and Francesco Blasi and Michele Bartoletti and Valeria Cento and Stefano Aliberti and Antonio Voza},
journal = {IJID Regions},
year = {2026},
month = oct,
doi = {10.1016/j.ijregi.2026.101032},
url = {https://doi.org/10.1016/j.ijregi.2026.101032},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Comparative outcomes of influenza, severe acute respiratory syndrome coronavirus 2, and respiratory syncytial virus community-acquired pneumonia: insights from an Italian retrospective cohort study
AU - Margherita S. Silani
AU - Anna Stainer
AU - Massimiliano Russo
AU - Antonio Desai
AU - Sofia Giuriolo
AU - Aniello Fabio Vitale
AU - Vincenzo Alberto Artuso
AU - Angela Tramontano
AU - Francesco Amati
AU - Beatrice Clemente
AU - Alessandra Belati
AU - Francesco Blasi
AU - Michele Bartoletti
AU - Valeria Cento
AU - Stefano Aliberti
AU - Antonio Voza
PY - 2026
DA - 2026/10/04
JO - IJID Regions
DO - 10.1016/j.ijregi.2026.101032
UR - https://doi.org/10.1016/j.ijregi.2026.101032
AB - Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality worldwide. Viral pathogens, particularly influenza, respiratory syncytial virus, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are increasingly recognized as key contributors to CAP in hospitalized adults. This single-center, retrospective cohort study examined and compared the clinical characteristics and outcomes of adults hospitalized with viral CAP due to influenza, SARS-CoV-2, or respiratory syncytial virus between January 2022 and December 2023 in Milan, Italy. A total of 165 patients with laboratory-confirmed single-virus infection and clinically and radiologically confirmed pneumonia were included. Patients with SARS-CoV-2 pneumonia presented with the highest in-hospital mortality (20.9%) and 12-month all-cause mortality (51.9%). Patients with influenza, although younger, showed increased rates of cardiovascular events and intensive care unit admissions. Bacterial coinfections were most common in influenza cases. Immunocompromised status was the second most frequent comorbidity (37.6%) after arterial hypertension. These findings underscore significant differences in clinical trajectory and long-term outcomes among major viral CAP etiologies and support the need for pathogen-specific management strategies.
SN - 2772-7076
ER -